The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 01, 2005
Filed:
Mar. 11, 2002
Stuart B. Rosenblum, West Orange, NJ (US);
Qingbei Zeng, Edison, NJ (US);
Mwangi WA Mutahi, Fords, NJ (US);
Robert G. Aslanian, Rockaway, NJ (US);
Pauline C. Ting, New Providence, NJ (US);
Neng-yang Shih, North Caldwell, NJ (US);
Daniel M. Solomon, Edison, NJ (US);
Jianhua Cao, Scotch Plains, NJ (US);
Henry A. Vaccaro, South Plainfield, NJ (US);
Kevin D. Mccormick, Edison, NJ (US);
John J. Baldwin, Gwynedd Valley, PA (US);
GE LI, Shanghai, CN;
Stuart B. Rosenblum, West Orange, NJ (US);
Qingbei Zeng, Edison, NJ (US);
Mwangi Wa Mutahi, Fords, NJ (US);
Robert G. Aslanian, Rockaway, NJ (US);
Pauline C. Ting, New Providence, NJ (US);
Neng-Yang Shih, North Caldwell, NJ (US);
Daniel M. Solomon, Edison, NJ (US);
Jianhua Cao, Scotch Plains, NJ (US);
Henry A. Vaccaro, South Plainfield, NJ (US);
Kevin D. McCormick, Edison, NJ (US);
John J. Baldwin, Gwynedd Valley, PA (US);
Ge Li, Shanghai, CN;
Schering Corporation, Kenilworth, NJ (US);
Pharmacopeia Drug Discovery, Inc., Cranbury, NJ (US);
Abstract
Disclosed are novel compounds of the formula Also disclosed are pharmaceutical compositions comprising the compounds of Formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I in combination with a H. receptor antagonist.